ATE501728T1 - Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten - Google Patents

Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten

Info

Publication number
ATE501728T1
ATE501728T1 AT04740883T AT04740883T ATE501728T1 AT E501728 T1 ATE501728 T1 AT E501728T1 AT 04740883 T AT04740883 T AT 04740883T AT 04740883 T AT04740883 T AT 04740883T AT E501728 T1 ATE501728 T1 AT E501728T1
Authority
AT
Austria
Prior art keywords
lpi
poly
activity
lectin pathway
peptides
Prior art date
Application number
AT04740883T
Other languages
English (en)
Inventor
Wamel Willem Van
Suzan Rooijakkers
KESSEL Cornelis VAN
STRIJP Johannes VAN
Original Assignee
Umc Utrecht Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Umc Utrecht Holding Bv filed Critical Umc Utrecht Holding Bv
Application granted granted Critical
Publication of ATE501728T1 publication Critical patent/ATE501728T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT04740883T 2003-07-08 2004-07-08 Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten ATE501728T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03077138 2003-07-08
PCT/EP2004/007606 WO2005005630A2 (en) 2003-07-08 2004-07-08 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases

Publications (1)

Publication Number Publication Date
ATE501728T1 true ATE501728T1 (de) 2011-04-15

Family

ID=34042904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04740883T ATE501728T1 (de) 2003-07-08 2004-07-08 Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten

Country Status (6)

Country Link
US (1) US20110118194A1 (de)
AT (1) ATE501728T1 (de)
DE (1) DE602004031836D1 (de)
DK (1) DK1641926T3 (de)
ES (1) ES2360399T3 (de)
WO (1) WO2005005630A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103118A2 (en) * 2005-04-01 2006-10-05 Umc Utrecht Holding B.V. Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases
US8524453B2 (en) 2006-02-10 2013-09-03 The Brigham And Woman's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
EP2861246B1 (de) * 2012-06-18 2021-01-20 Omeros Corporation Zusammensetzungen und verfahren zur hemmung von masp-1 und/oder masp-2 und/oder masp-3 zur behandlung verschiedener erkrankungen und störungen
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331758T2 (de) 1992-09-21 2002-11-14 Alfa-Laval Agri International Ab, Tumba Fibrinogen-bildungsprotein
US6737248B2 (en) * 1996-01-05 2004-05-18 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
CN1309662A (zh) * 1998-07-10 2001-08-22 亚利制药有限公司 葡萄球菌属的趋化性抑制蛋白(chips)及其应用
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
EP1608756B1 (de) * 2003-03-31 2009-11-18 Intercell AG Staphylococcus epidermidis antigene
US20090202437A1 (en) * 2003-07-08 2009-08-13 Willem Jan Bastiaan Van Wamel Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases
WO2006103118A2 (en) * 2005-04-01 2006-10-05 Umc Utrecht Holding B.V. Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases

Also Published As

Publication number Publication date
ES2360399T3 (es) 2011-06-03
WO2005005630A2 (en) 2005-01-20
WO2005005630A3 (en) 2005-06-23
DE602004031836D1 (de) 2011-04-28
US20110118194A1 (en) 2011-05-19
DK1641926T3 (da) 2011-06-27

Similar Documents

Publication Publication Date Title
WO2007010401A3 (en) Glycosylated il-7, preparation and uses
EP3461844A3 (de) Verbesserte, gegen il-6r gerichtete aminosäuresequenzen und polypeptide damit zur behandlung von erkrankungen und störungen im zusammenhang mit il-6r
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
MX2010005783A (es) Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas.
MXPA03001984A (es) Variantes de factor vii de coagulacion humano.
MX2009012650A (es) Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos.
WO2007104529A3 (en) Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
ATE485371T1 (de) Varianten des menschlichen koagulationsfaktors vii
TW200407425A (en) Human coagulation factor VII polypeptides
EA201200515A1 (ru) Полипептиды и их применение
AU2003266214A1 (en) Human coagulation factor vii polypeptides
BRPI0411363A (pt) seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas
WO2009001260A3 (en) Cosmetic use of apolipoprotein d type proteins
NO20070640L (no) Forbedrede aprotininvananter
PL1622939T3 (pl) Aktywne warianty białka wiążącego IL-18 i ich medyczne zastosowania
DE602004031836D1 (de) Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten
WO2002102316A3 (en) Histone deacetylase and methods of use thereof
NO20023248D0 (no) Nukleinsyrer som koder for (poly)peptider med CHIPS-aktivitet
WO2008068428A3 (fr) Utilisation cosmétique de protéines de type chitinase
ATE539086T1 (de) Interleukin-11-fusionsproteine
IL169256A (en) Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it
EA200600314A1 (ru) Использование растворимого cd164 при воспалительных и/или аутоимунных нарушениях
BG101846A (bg) Варианти на човешка дезоксирибонуклеаза i
WO2002034882A3 (en) Genes regulating programmed cell death
ATE400288T1 (de) Peptide mit hohem cysteingehalt

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties